A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

Bayer

Status: Completed

Conditions: Ophthalmology, Macular Degeneration

Treatments: Other: Physician questionnaire

Study type: Observational

Funder types: Industry

Identifiers

NCT04067583

20285

Details and patient eligibility

About

With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.

Enrollment: 454 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Has signed informed consent
• Is a licensed and practicing ophthalmologist
• Has prescribed and/or administered aflibercept to at least one patient in the past 6 months

Exclusion criteria

• None

Trial design

454 participants in 1 patient group

Physicians with recent aflibercept experience

Description:

Ophthalmologists who have prescribed and/or administered aflibercept in the past 6 months

Treatment:

Other: Physician questionnaire